.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Cantor Fitzgerald
Federal Trade Commission
Dow
Johnson and Johnson
Novartis
Deloitte
US Army
Merck
Healthtrust

Generated: November 21, 2017

DrugPatentWatch Database Preview

Perindopril erbumine - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for perindopril erbumine and what is the scope of perindopril erbumine patent protection?

Perindopril erbumine
is the generic ingredient in two branded drugs marketed by Ani Pharms Inc, Apotex, Lupin Ltd, Aurobindo Pharma, West-ward Pharms Int, and Symplmed Pharms Llc, and is included in six NDAs. Additional information is available in the individual branded drug profile pages.

There are fourteen drug master file entries for perindopril erbumine. Six suppliers are listed for this compound.

Summary for perindopril erbumine

Pharmacology for perindopril erbumine

Medical Subject Heading (MeSH) Categories for perindopril erbumine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lupin Ltd
PERINDOPRIL ERBUMINE
perindopril erbumine
TABLET;ORAL078263-001Jan 27, 2010DISCNNoNo► Subscribe► Subscribe► Subscribe
Ani Pharms Inc
PERINDOPRIL ERBUMINE
perindopril erbumine
TABLET;ORAL078138-001Nov 10, 2009ABRXNoNo► Subscribe► Subscribe► Subscribe
Lupin Ltd
PERINDOPRIL ERBUMINE
perindopril erbumine
TABLET;ORAL078263-002Jan 27, 2010DISCNNoNo► Subscribe► Subscribe► Subscribe
Symplmed Pharms Llc
ACEON
perindopril erbumine
TABLET;ORAL020184-001Dec 30, 1993DISCNYesNo► Subscribe► Subscribe► Subscribe
Apotex
PERINDOPRIL ERBUMINE
perindopril erbumine
TABLET;ORAL090463-002Aug 30, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
West-ward Pharms Int
PERINDOPRIL ERBUMINE
perindopril erbumine
TABLET;ORAL090072-001Nov 10, 2009ABRXNoNo► Subscribe► Subscribe► Subscribe
Aurobindo Pharma
PERINDOPRIL ERBUMINE
perindopril erbumine
TABLET;ORAL079070-001Nov 10, 2009ABRXNoYes► Subscribe► Subscribe► Subscribe
West-ward Pharms Int
PERINDOPRIL ERBUMINE
perindopril erbumine
TABLET;ORAL090072-003Nov 10, 2009ABRXNoNo► Subscribe► Subscribe► Subscribe
Ani Pharms Inc
PERINDOPRIL ERBUMINE
perindopril erbumine
TABLET;ORAL078138-003Nov 10, 2009ABRXNoNo► Subscribe► Subscribe► Subscribe
Apotex
PERINDOPRIL ERBUMINE
perindopril erbumine
TABLET;ORAL090463-001Aug 30, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: perindopril erbumine

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Symplmed Pharms Llc
ACEON
perindopril erbumine
TABLET;ORAL020184-001Dec 30, 1993► Subscribe► Subscribe
Symplmed Pharms Llc
ACEON
perindopril erbumine
TABLET;ORAL020184-002Dec 30, 1993► Subscribe► Subscribe
Symplmed Pharms Llc
ACEON
perindopril erbumine
TABLET;ORAL020184-003Dec 30, 1993► Subscribe► Subscribe
Symplmed Pharms Llc
ACEON
perindopril erbumine
TABLET;ORAL020184-003Dec 30, 1993► Subscribe► Subscribe
Symplmed Pharms Llc
ACEON
perindopril erbumine
TABLET;ORAL020184-002Dec 30, 1993► Subscribe► Subscribe
Symplmed Pharms Llc
ACEON
perindopril erbumine
TABLET;ORAL020184-001Dec 30, 1993► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Argus Health
McKinsey
Federal Trade Commission
Teva
US Army
Mallinckrodt
Daiichi Sankyo
Johnson and Johnson
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot